Atomic structure of a rationally engineered gene delivery vector, AAV2.5

被引:20
|
作者
Burg, Matthew [1 ]
Rosebrough, Claire [1 ]
Drouin, Lauren M. [1 ,6 ]
Bennett, Antonette [1 ]
Mietzsch, Mario [1 ]
Chipman, Paul [1 ]
McKenna, Robert [1 ]
Sousa, Duncan [2 ]
Potter, Mark [3 ,4 ]
Byrne, Barry [3 ,4 ]
Samulski, R. Jude [5 ]
Agbandje-McKenna, Mavis [1 ]
机构
[1] Univ Florida, Coll Med, Dept Biochem & Mol Biol, McKnight Brain Inst, Gainesville, FL 32610 USA
[2] Florida State Univ, Dept Biol Sci, Biol Sci Imaging Resource, 89 Chieftan Way,Rm 119, Tallahassee, FL 32306 USA
[3] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA
[5] Univ N Carolina, Dept Pharmacol, Gene Therapy Ctr, Chapel Hill, NC 27515 USA
[6] Voyager Therapeut Inc, Cambridge, MA USA
关键词
Adeno-associated virus; cryo-EM; Vector engineering; Structure-guided design; Parvovirus; THERAPY; TRANSDUCTION; INSIGHTS; BINDING; CELLS; MODEL;
D O I
10.1016/j.jsb.2018.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AAV2.5 represents the first structure-guided in-silica designed Adeno-associated virus (AAV) gene delivery vector. This engineered vector combined the receptor attachment properties of AAV serotype 2 (AAV2) with the muscle tropic properties of AAV1, and exhibited an antibody escape phenotype because of a modified antigenic epitope. To confirm the design, the structure of the vector was determined to a resolution of 2.78 angstrom using cryo-electron microscopy and image reconstruction. The structure of the major viral protein (VP), VP3, was ordered from residue 219 to 736, as reported for other AAV structures, and the five AAV2.5 residues exchanged from AAV2 to AAV1, Q263A, T265 (insertion), N706A, V709A, and T717N, were readily interpretable. Significantly, the surface loops containing these residues adopt the AAV1 conformation indicating the importance of amino acid residues in dictating VP structure.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 50 条
  • [41] AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models
    Albert, Katrina
    Voutilainen, Merja H.
    Domanskyi, Andrii
    Airavaara, Mikko
    GENES, 2017, 8 (02):
  • [42] The structure of AAVrh32.33, a novel gene delivery vector
    Mikals, Kyle
    Nam, Hyun-Joo
    Van Vliet, Kim
    Vandenberghe, Luk H.
    Mays, Lauren E.
    McKenna, Robert
    Wilson, James M.
    Agbandje-McKenna, Mavis
    JOURNAL OF STRUCTURAL BIOLOGY, 2014, 186 (02) : 308 - 317
  • [43] The Structure of AAVrh32.33, a Novel Gene Delivery Vector
    Mikals, Kyle
    Nam, Hyun-Joo
    Van Vliet, Kim
    Vandenberghe, Luk H.
    Mays, Lauren E.
    McKenna, Robert
    Wilson, James M.
    Agbandje-McKenna, Mavis
    MOLECULAR THERAPY, 2013, 21 : S29 - S29
  • [44] AAVmod2, an AAV Capsid Engineered to Independently Detarget the Liver and Enhance Gene Delivery to Skeletal Muscle
    Olivieri, Kevin
    Thorpe, Zachary
    Craig, Stewart
    Sanders, Doug
    Te, Levy
    Vandenberghe, Luk H.
    Richman, Laura K.
    Tipper, Christopher
    MOLECULAR THERAPY, 2021, 29 (04) : 145 - 146
  • [45] In Vivo Gene Delivery Using Exosomes Engineered to Contain AAV Improves Transduction Efficiency and Resists Neutralizing Antibodies
    McConnell, Russell
    Lule, Sevda
    Zi, Tong
    Jang, Su Chul
    Noyes, Aaron
    Sathy, Sriram
    MOLECULAR THERAPY, 2023, 31 (04) : 237 - 238
  • [46] Subretinal delivery of recombinant AAV serotype 8 vector in dogs results in gene transfer to neurons in the brain
    Stieger, Knut
    Colle, Marie-Anne
    Dubreil, Laurence
    Mendes-Madeira, Alexandra
    Weber, Michel
    Le Meur, Guylene
    Deschamps, Jack Yves
    Provost, Nathalie
    Nivard, Delphine
    Cherel, Yan
    Moullier, Philippe
    Rolling, Fabienne
    MOLECULAR THERAPY, 2008, 16 (05) : 916 - 923
  • [47] The Structure of an AAV5-AAVR Complex at 2.5 A Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors
    Silveria, Mark A.
    Large, Edward E.
    Zane, Grant M.
    White, Tommi A.
    Chapman, Michael S.
    VIRUSES-BASEL, 2020, 12 (11):
  • [48] Structure-guided AAV capsid evolution strategies for enhanced CNS gene delivery
    Trevor J. Gonzalez
    Aaron Mitchell-Dick
    Leo O. Blondel
    Marco M. Fanous
    Joshua A. Hull
    Daniel K. Oh
    Sven Moller-Tank
    Ruth M. Castellanos Rivera
    Jorge A. Piedrahita
    Aravind Asokan
    Nature Protocols, 2023, 18 : 3413 - 3459
  • [49] Structure-guided AAV capsid evolution strategies for enhanced CNS gene delivery
    Gonzalez, Trevor J.
    Mitchell-Dick, Aaron
    Blondel, Leo O.
    Fanous, Marco M.
    Hull, Joshua A.
    Oh, Daniel K.
    Moller-Tank, Sven
    Rivera, Ruth M. Castellanos
    Piedrahita, Jorge A.
    Asokan, Aravind
    NATURE PROTOCOLS, 2023, 18 (11) : 3413 - +
  • [50] Delivery of Large Gene Circuits In Vivo Using an Engineered Baculovirus Vector for Multifactorial Control of Therapeutic Gene Expression
    Brown, Lucas B. C.
    Zhang, Linlin
    Bao, Gang
    Bashor, Caleb J.
    MOLECULAR THERAPY, 2024, 32 (04) : 87 - 88